Want to see KR:009420 full AI Analyst Report?
Hanall Biopharma Co., Ltd. (009420) Ownership - Who Owns Hanall Biopharma Co., Ltd.?
Hanall Biopharma Co., Ltd. (009420) Ownership Overview
- 1.83% Mutual Funds
- 3.28% ETFs
- 94.89% Public Companies and Individual Investors
The ownership structure of Hanall Biopharma Co., Ltd. (KR:009420) stock is a mix of institutional, retail, and individual investors. Approximately 5.11% of the company’s stock is owned by Institutional Investors, and 94.89% is owned by Public Companies and Individual Investors.
The ownership structure of Hanall Biopharma Co., Ltd. (KR:009420) stock is a mix of institutional, retail, and individual investors. Approximately 5.11% of the company’s stock is owned by Institutional Investors, and 94.89% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 909,814 | Institution | 1.74% | 25,586,699 |
| Ishares | 615,470 | Institution | 1.18% | 17,308,863 |
| Vanguard Star Funds | 435,851 | Institution | 0.83% | 12,257,438 |
| Vanguard Tax-managed Funds | 288,382 | Institution | 0.55% | 8,110,167 |
| Vanguard International Equity Index Funds | 171,470 | Institution | 0.33% | 4,822,251 |
| State Street | 91,054 | Institution | 0.17% | 2,560,712 |
| Schwab | 60,880 | Institution | 0.12% | 1,712,128 |
| Fidelity Salem Street Trust | 22,589 | Institution | 0.04% | 635,270 |
| Dimensional | 19,245 | Institution | 0.04% | 541,227 |
| Spdr | 14,622 | Institution | 0.03% | 411,215 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 435,851 | Institution | 0.83% | 12,257,438 |
| Vanguard Tax-managed Funds | 288,382 | Institution | 0.55% | 8,110,167 |
| Vanguard International Equity Index Funds | 171,470 | Institution | 0.33% | 4,822,251 |
| Fidelity Salem Street Trust | 22,589 | Institution | 0.04% | 635,270 |
| Dfa Investment Dimensions Group Inc | 13,013 | Institution | 0.02% | 365,965 |
| State Street Institutional Investment Trust | 12,699 | Institution | 0.02% | 357,134 |
| Fidelity Concord Street Trust | 10,427 | Institution | 0.02% | 293,239 |
| Eaton Vance Series Trust Ii | 3,438 | Institution | <0.01% | 96,687 |
| Pace Select Advisors Trust | 258 | Institution | <0.01% | 7,256 |
| Franklin Alternative Strategies Funds | 1 | Institution | <0.01% | 28 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 435,851 | Institution | 0.83% | 14,013,100 |
| iShares, IEMG ETF | 372,684 | Institution | 0.71% | 10,537,353 |
| Vanguard, VEA ETF | 288,382 | Institution | 0.55% | 9,271,798 |
| Vanguard, VSS ETF | 110,780 | Institution | 0.21% | 3,561,699 |
| State Street, SPDW ETF | 89,850 | Institution | 0.17% | 2,541,212 |
| Schwab, SCHC ETF | 60,880 | Institution | 0.12% | 1,721,859 |
| iShares, IXUS ETF | 54,805 | Institution | 0.10% | 1,549,569 |
| Vanguard, VPL ETF | 32,134 | Institution | 0.06% | 1,033,143 |
| Vanguard, VT ETF | 24,023 | Institution | 0.05% | 772,366 |
| iShares, GB:SEDM ETF | 15,058 | Institution | 0.03% | 425,883 |
FAQ
What percentage of Hanall Biopharma Co., Ltd. (KR:009420) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.11% of Hanall Biopharma Co., Ltd. (KR:009420) stock is held by institutional investors: 1.83% by mutual funds and 3.28% by ETFs.
What percentage of Hanall Biopharma Co., Ltd. (KR:009420) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.89% of Hanall Biopharma Co., Ltd. (KR:009420) stock is held by public companies and individual investors.
Who owns the most shares of Hanall Biopharma Co., Ltd. (KR:009420)?
Vanguard owns the most shares of Hanall Biopharma Co., Ltd. (KR:009420).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.